HOME | ISSUE ONE (Jan - Mar) 2017 HTML
HUMANITIES SCIENCE POLITICS
Science, People & Politics ISSN 1751-598X
NEWS | 7
than to words developed for litigation. By "The Time" the judges mean when UC inventors published their research in Science [Jinek et al] in August 2012(1). The judges write, "... we are still persuaded by Dr Carroll's statement made contemporaneously to Jinek 2012 'There is no guarantee that cas9 will work effectively on a chromatin target or that the required DNA-RNA hybrid can be stabilized in that context... Only attempts to apply the system in eukaryotes will address these concerns." Though cited by the judges in support of their finding for the Broad, Dr Carroll was UC's expert witness. The judges write also that a scientist's enthusiasm for their own work is not a convincing argument that CRISPR-cas9 had an obvious chance of success in eukaryotes. Nor did they accept that because the application of CRISPR-cas9 had worked in eukaryotes that that meant it was obvious it would work. _________________ *CRISPR-cas is an acronym for Clustered Regularly Interspersed Short Palindromic Repeats associated with Cas. Cas is a protein. _________________ (1). Jinek et al (2012). "A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity", Science 337 pp 816-821 DOI: 10.1126/science.1225829 Helen Gavaghan edited the patents page in the technology section of New Scientist for three years as one of her duties during the 7 years she was on staff at the magazine.
ADVERT The next issue of Science, People & Politics Is Friday 26th May 2017
7
Issue 1 (Jan-Mar), 2017............................................Science, People & Politics ISSN 1751-598X print and online
||**
CONTENTS
P3
P4
P5
P6
P7
P8
P10
P12
P13
P14
P15
P16
Published Friday 24th February, 2017, nominally.Completed 9th April, 2017.
P17
P18
P19
P20
P21
P22
P23
P24
P25
P26
P27
P28
P29
P30
P31
HTML/CSS by Helen Gavaghan©